Cancer Gene Therapy
Trifunctional molecule designed for DNA recognition
Published in Gene Therapy Weekly, March 13th, 2003
"Control of gene expression is a cherished goal of cancer chemotherapy. Small ligand molecules able to bind tightly to DNA in a well-defined configuration are being actively searched for. With this goal in mind, we have designed and synthesized the trifunctional molecule R-132, which combines a bispyrrole skeleton for minor groove DNA recognition and two different chromophores, anilinoacridine and ethidium," wrote C. Carrasco and colleagues, University of Paris 05, Faculty of Pharmaceutical & Biological Science.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2003-03-13)
More Articles from Gene Therapy Weekly
- Acute Leukemia
Researchers have completed a phase 1 study of antisense therapy G3139 - Inflammatory Bowel Disease
Interleukin-10 gene therapy ameliorates colitis in animal models - Ovarian Cancer
The CD40 receptor can be useful target for cancer gene therapies - Gene Repair
Single-stranded oligonucleotides direct nucleotide replacement at two sites - Gene Transfer
Porous scaffolds facilitate delivery of nonviral DNA - Spermatogenesis
Seminiferous tubule cannulation a new technique for detecting gene transfer - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
